About Optellum
Optellum is a pioneering healthcare AI company that develops decision-support software for the early diagnosis and optimal treatment of lung disease, with a primary focus on lung cancer. Their flagship product, the Virtual Nodule Clinic (VNC), utilizes advanced Artificial Intelligence (AI) and Machine Learning (ML) to analyze imaging data and calculate a Lung Cancer Prediction (LCP) score. This score helps physicians identify and quantify the probability of malignancy in detected lung nodules, enabling earlier and more accurate diagnoses.
The company’s AI-powered platform is designed to assist radiologists and pulmonologists in managing lung nodules, supporting screening programs, and detecting high-risk incidental nodules from various CT reports. The VNC has received regulatory clearances including U.S. FDA 510(k), CE Mark in the EU, and UKCA approval, and is associated with a CPT® code for AI-based lung nodule risk assessment and management, allowing for Medicare reimbursement. Optellum collaborates with leading medical institutions and industry partners, including GE Healthcare and Johnson & Johnson’s Lung Cancer Initiative, to advance precision diagnosis and treatment of lung cancer.
Focus Areas
Business Intelligence
| Technology | Cloud-native, AI-powered platform for medical image analysis |
What Physicians Need to Know
Optellum's Virtual Nodule Clinic with LCP AI provides physicians with a powerful tool to enhance early lung cancer diagnosis and streamline lung nodule management. The platform's ability to automatically identify at-risk patients via NLP, provide a clinically validated cancer risk score, and integrate seamlessly with existing EHR and PACS systems can significantly reduce time to diagnosis and improve patient follow-up rates. This allows for earlier, potentially curative interventions and reduces unnecessary procedures for benign lesions, ultimately optimizing care pathways and resource allocation. The FDA clearance and Medicare reimbursement for LCP AI also provide a clear pathway for adoption and financial sustainability.
Optellum's Virtual Nodule Clinic is designed for seamless integration with existing Electronic Health Record (EHR) and Picture Archiving and Communication Systems (PACS) using standard technologies like HL7 and DICOM. This allows for automated retrieval of patient information, reports, and images without disrupting clinical workflows. Optellum has also established partnerships for integration with platforms such as RapidAI's Rapid Enterprise™ Platform and is exploring collaborations with Coreline Soft and GE HealthCare to further expand AI integration into imaging and lung health solutions.
What the Web Says
Optellum is an AI healthcare company focused on early diagnosis and treatment of lung disease, particularly lung cancer. Their flagship product, the Virtual Nodule Clinic (VNC) with Lung Cancer Prediction AI (LCP), is an FDA-cleared and reimbursed software-as-a-medical-device (SaMD) solution. It helps clinicians manage lung nodules, prioritize patients, and make informed decisions about follow-up, biopsy, and treatment. The company has received positive attention for its innovative AI technology and its potential to improve patient outcomes.
Overall: PositiveStrengths
- AI-powered lung cancer prediction and diagnostic support.
- FDA-cleared, CE and UKCA marked, and Medicare-reimbursed.
- Helps with earlier lung cancer diagnosis and reduces unnecessary biopsies.
- Automates the identification of patients with lung nodules from radiology reports.
- Provides workflow management tools for patient tracking and follow-up.
- Cost-effective solution for lung nodule risk stratification.
Limitations
- Strong fit for health systems with lung nodule clinics, but a weak fit for radiology groups seeking broad triage AI across many findings.
- Not suitable for sites with too few chest CT scans to run a nodule program.
- Buyers may not have a published price list.
- Limited information available on employer reviews from major platforms like Glassdoor or Indeed specifically for "Optellum" (reviews for "Optum" and "Optel Group" were found but are distinct companies).
Based on reviews from: Healthcare Industry Reviews, PR Newswire, Reddit, Indeed.com, accessdata.fda.gov, Simplify Jobs, Community Stories - Optellum's AI-Powered Journey with EIT Health, ITN Product Buyer's Guide
Last updated: 2026-10-23
Videos
News, demos, and interviews about Optellum.
Videos load interactively. If none appear, search YouTube for Optellum →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Optellum.
Comparisons
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]